Analysts expect Celularity Inc to report revenue of 4.70 M for Q1 24, against a range of 4.32 M to 5.09 M.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | - | - | - | - | - | - | ||||||||||||
| High Estimate | 5.09 M | 5.09 M | 6.10 M | 5.94 M | 5.51 M | 6.11 M | 6.89 M | 6.63 M | ||||||||||||
| Low Estimate | 4.32 M | 4.23 M | 5.11 M | 4.94 M | 5.11 M | 5.34 M | 5.74 M | 5.77 M | ||||||||||||
| Consensus Estimate | 4.70 M | 4.66 M | 5.61 M | 5.44 M | 5.31 M | 5.73 M | 6.31 M | 6.20 M |
Analysts expect Celularity Inc to report earnings per share of -1.31 for Q1 24, against a range of -1.41 to -1.21. The most recent reported quarter, Q2 25, came in at -1.02, a 43.7% miss against the -0.71 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | - | - | -0.75 | -1.02 | - | - | - | - | ||||||||||
| High Estimate | -1.21 | -1.39 | -1.30 | -1.34 | - | -0.68 | -1.28 | -1.34 | -0.30 | -0.41 | ||||||||||
| Low Estimate | -1.41 | -1.55 | -1.42 | -1.50 | - | -0.74 | -1.56 | -1.58 | -0.32 | -0.45 | ||||||||||
| Consensus Estimate | -1.31 | -1.47 | -1.36 | -1.42 | - | -0.71 | -1.42 | -1.46 | -0.31 | -0.43 |